NZ HERALD: Otago University biomedical researchers have been awarded a $950,000 Health Research Council Grant for a three-year project to investigate the likely role of a protein, activin C, in promoting prostate cancer growth. READ MORE>
Archive for August, 2009
Otago researchers get nearly $1 million to research prostate cancer protein
Posted in PROSTATE CANCER, PROSTATE RESEARCH, tagged activin C, cancer research, Health Research Council Grant, NZ Herald, Otago University biomedical researchers, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer growth, protein, Screening debate on August 31, 2009| Leave a Comment »
Obesity drug tested on mice also affects prostate cancer cells
Posted in PROSTATE CANCER, PROSTATE RESEARCH, tagged cancer research, cure for obesity, links between prostate cancer and obesity, lowers cholesterol, mice lose weight, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer cells, reverses diabetes, YAHOO XTRA NEWS on August 31, 2009| Leave a Comment »
YAHOO XTRA NEWS: Researchers searching for a cure for obesity have developed a drug that not only makes mice lose weight, but reverses diabetes, lowers their cholesterol, has effects on prostate cancer cells – something that may help explain links between prostate cancer and obesity. READ MORE>
NZ’s drug agency, Pharmac, agrees to fund prostate drug for another three years
Posted in Chemotherapy, PROSTATE CANCER, Treatment news, tagged advanced prostate cancer, AstraZeneca, intravenous prostate cancer treatment drug, NZ Doctor, Pharmac, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, subsidy and delisting protection, Zoladex on August 31, 2009| Leave a Comment »
NZ DOCTOR: Restrictions on access to intravenous prostate cancer treatment drug Zoladex (goserelin) will be lifted tomorrow in an agreement that sees Pharmac continuing to fully subsidise the drug. As part of the same agreement with manufacturer AstraZeneca, a special authority will no longer be required for the drug, which will have subsidy and delisting protection until June 30, 2013. READ MORE>
Tomatoes turn blue in Wattie’s efforts to support prostate cancer awareness month
Posted in Blue September, PROSTATE CANCER, tagged Blue September, donating 5c a can, NZ Prostate Cancer Foundation's Blue September campaign, prostablog, prostate, prostate blog, PROSTATE CANCER, Wattie's, Wattie's canned tomato, Wattie's canned tomato products on August 31, 2009| Leave a Comment »
PROSTABLOG NZ: Canned food giant Wattie’s is doing its bit to support the NZ Prostate Cancer Foundation’s Blue September campaign by donating 5c a can from every sale of Wattie’s canned tomato sauce and Wattie’s canned tomato products featuring the Blue September label. READ MORE>
Suspicion grows over how terminal freed Lockerbie bomber’s prostate cancer is
Posted in PROSTATE CANCER, Prostate media coverage, tagged advanced prostate cancer, Lockerbie bomber, Megrahi, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer medical evidence, prostate prospects, SUNDAY HERALD (SCOTLAND), Suspicions growing, terminal on August 31, 2009| Leave a Comment »
SUNDAY HERALD (SCOTLAND): Suspicions are growing about the prostate cancer medical evidence used to justify the release of the man convicted of the Lockerbie bombing. READ MORE>
Blue September dawns in NZ – see coverage here
Posted in Blue September, PROSTATE CANCER, PROSTATE RESEARCH, tagged Blue Sept NZ, Blue September in NZ, Cobra sports cars, prostablog, prostate, prostate blog, PROSTATE CANCER, Prostate Cancer Foundation, Prostate Cancer Foundation of NZ on August 30, 2009| Leave a Comment »
PROSTABLOG NZ: Blue September – the Prostate Cancer Foundation of NZ’s annual awareness campaign – has started already. CLICK HERE>
Mobile clinic takes health checks for diseases like prostate cancer into American Indian communities
Posted in PROSTATE CANCER, PSA tests, Screening debate, tagged American Indians and prostate cancer, medical checkups, mobile clinic, mobile medical bus, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, prostate treatment debate, prostate-specific antigen, PSA, PSA test, Screening debate, SHAKOPEE VALLEY NEWS, state-of-the-art medical technology on August 30, 2009| Leave a Comment »
SHAKOPEE VALLEY NEWS: A $2 million, 16-wheel mobile unit with leather seats, computers, flat-screen televisions and state-of-the-art medical technology is being used to bring medical testing to American Indian populations in Minnesota. READ MORE>
Prostate cancer patients round world being tested with new anti-cancer agent that blocks tumour growth
Posted in New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged advanced prostate cancer, clinical trials, endothelin A, potential anti-cancer agent, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, PSA RISING.COM, shrink tumors, ZD4054 on August 30, 2009| Leave a Comment »
PSA RISING.COM: A potential anti-cancer agent called ZD4054 is being tested in clinical trials around the world in patients with prostate cancer to see if it can block the uptake of endothelin A and thereby shrink tumors or slow their progression. READ MORE>
New antagonist hormone drug overtakes 25-year-old agonist versions for treating advanced prostate cancer
Posted in Hormone therapy, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged acceptable safety profile, cancer research, Degarelix, Hormone therapy, LHRH agonist, LHRH antagonist, lowering serum testosterone levels, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, testosterone surges, URO TODAY on August 30, 2009| Leave a Comment »
URO TODAY: Degarelix, a recently approved LHRH antagonist, has been shown to work more quickly in lowering serum testosterone levels, with acceptable safety and a mechanism that avoids the testosterone surges associated with LHRH agonist use. READ MORE>
